Healthcare Policy

Healthcare Policy 13(4) May 2018 : 23-34.doi:10.12927/hcpol.2018.25496
Discussion and Debate

Ontario and New Zealand Pharmaceuticals: Cost and Coverage

Leah T. Kelley, Tim Tenbensel and Ana Johnson

Abstract

Ontario is a strong candidate for a comprehensive pharmacare program, given that it has a pre-existing public drug benefit program (the Ontario Drug Benefit Program [ODBP]). This paper outlines strategies from New Zealand's national pharmacare program (the Pharmaceutical Management Agency [PHARMAC]) and compares these strategies to other international examples. It is recommended that the ODBP engage in three strategies currently utilized by the PHARMAC to achieve significant cost savings and create potential to increase their insurance coverage: (i) strict budgeting; (ii) tendering and negotiating; and (iii) reference pricing.

 

Comments

Be the first to comment on this!

Related Articles

Note: Please enter a display name. Your email address will not be publically displayed